UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Respiratory research, 2009-09, Vol.10 (1), p.87-87, Article 87

2009

Volltextzugriff (PDF)

Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing

American journal of respiratory and critical care medicine, 2017-01, Vol.195 (1), p.23-31

2017

Volltextzugriff (PDF)

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12100-n/a

2022

Volltextzugriff (PDF)

Pulmonary hypertension in the child with bronchopulmonary dysplasia

Pediatric pulmonology, 2021-11, Vol.56 (11), p.3546-3556

2021

Volltextzugriff (PDF)

Liver abnormalities in pulmonary arterial hypertension

Pulmonary Circulation, 2021-10, Vol.11 (4), p.1-12

2021

Volltextzugriff (PDF)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia

American journal of respiratory and critical care medicine, 2020-10, Vol.202 (8), p.1075-1077

2020

Volltextzugriff (PDF)

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Pulmonary circulation, 2023-07, Vol.13 (3), p.e12284-n/a

2023

Volltextzugriff (PDF)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2020-06, Vol.201 (11), p.1329-1331

2020

Volltextzugriff (PDF)

Developing a Broader Understanding of Pediatric PAH Worldwide

Chest, 2023-06, Vol.163 (6), p.1353-1355

2023

Volltextzugriff (PDF)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms

Pulmonary circulation, 2023-01, Vol.13 (1), p.e12185-n/a

2023

Volltextzugriff (PDF)

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Pulmonary circulation, 2022-04, Vol.12 (2), p.e12039-n/a

2022

Volltextzugriff (PDF)

Gender, sex hormones and pulmonary hypertension

Pulmonary Circulation, 2013-04, Vol.3 (2), p.294-314

2013

Volltextzugriff (PDF)

BMPR2 expression is suppressed by signaling through the estrogen receptor

Biology of sex differences, 2012-02, Vol.3 (1), p.6-6

2012

Volltextzugriff (PDF)

Pulmonary Hypertension in Children

Clinics in chest medicine, 2024-09, Vol.45 (3), p.685-693

2024

Volltextzugriff (PDF)

Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers

Cell stem cell, 2017-04, Vol.20 (4), p.490-504.e5

2017

Volltextzugriff (PDF)

Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2022-07, Vol.206 (1), p.8-10

2022

Volltextzugriff (PDF)

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-5

2020

Volltextzugriff (PDF)

End Stage Takes Center Stage in Pulmonary Arterial Hypertension

American journal of respiratory cell and molecular biology, 2019-06, Vol.60 (6), p.607-608

2019

Volltextzugriff (PDF)

Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment

Clinical therapeutics, 2023-09, Vol.45 (9), p.901-912

2023

Volltextzugriff (PDF)

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-05, Vol.133 (20), p.1936-1944

2016

Volltextzugriff (PDF)

TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form

The European respiratory journal, 2020-05, Vol.55 (5), p.2000585

2020

Volltextzugriff (PDF)

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

Frontiers in medicine, 2020-09, Vol.7, p.540-540

2020

Volltextzugriff (PDF)

The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension

ERJ open research, 2021-10, Vol.7 (4), p.378

2021

Volltextzugriff (PDF)

Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (7), p.858-859

2018

Volltextzugriff (PDF)

26 – 50 von 620

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(575)
Mit Volltextzugriff
(522)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(619)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension

Pulmonary hypertension in the child with bronchopulmonary dysplasia

Liver abnormalities in pulmonary arterial hypertension

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia

Kids Mod PAH trial: A multicenter trial comparing mono‐ versus duo‐therapy for initial treatment of pediatric pulmonary hypertension

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension

Developing a Broader Understanding of Pediatric PAH Worldwide

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Gender, sex hormones and pulmonary hypertension

BMPR2 expression is suppressed by signaling through the estrogen receptor

Pulmonary Hypertension in Children

Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers

Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension

End Stage Takes Center Stage in Pulmonary Arterial Hypertension

Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension

Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension

Aktive Filter

Suchergebnisse filtern